AHA Stat Blog: Report misses mark on 340B program

AHA News Now

The latest report from a group financed and backed by the pharmaceutical industry “continues to misrepresent” the 340B Drug Pricing Program and its “successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, drug prices

Senators urge CMS to consider stakeholders' concerns on 340B proposal

AHA News

Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services (CMS) to “carefully consider stakeholder feedback” before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “The long-term success of the 340B program... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, advocacy, access

Protect 340B and Preserve the Safety Net

Blog

The panel that advises the Centers for Medicare & Medicaid Services on hospital outpatient payments sent a clear signal to the agency this week: Don’t shortchange patients’ access to vital pharmaceuticals by cutting the 340B Drug Pricing Program. CMS’s Advisory Panel on Hospital Outpatient Payment... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: Drug Pricing Program, advocacy, access

Hospitals, not pharmaceutical manufacturers, are preserving and protecting the safety net

Blog

A group financed by the pharmaceutical industry is hosting a meeting today on the 340B Drug Pricing Program with the goal of “Preserving the True Safety Net.” But what the meeting really will be about is the pharmaceutical industry – with their skyrocketing prescription drug prices and huge profits –... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, Community benefit, access, drug prices

Changing 340B is the wrong prescription for addressing skyrocketing pharmaceutical costs

Blog

The rapidly rising costs of prescription drugs is causing significant financial challenges for patients and their care providers.

Many groups, including the AHA, are evaluating options for addressing this important issue. However, one recent proposal, which is seriously misguided, would reduce a program... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

Amid concerns of possible policy changes, hospitals brief Congress on 340B's benefits

AHA News

At an AHA-sponsored briefing Nov. 19 on Capitol Hill, hospital leaders urged Congress to protect the 340B Drug Pricing Program, and shared with congressional staff the benefits that the program brings to vulnerable patients.

“People within the communities that Trinity Health serves receive tremendous and... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, access

Protect Patients. Preserve 340B.

Blog

More than 20 years ago, Congress created the 340B Drug Pricing Program to allow eligible hospitals and health systems to stretch limited resources and expand access to care for vulnerable patients. But despite a proven track record of increasing patient access to vital medical services and decreasing... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

340B Proposals Would Jeopardize Hospitals' Ability to Serve Vulnerable Patients

Blog

The 340B Drug Pricing Program has a strong track record of helping to combat high prescription drug prices and increase access to vital medicines and comprehensive health care services for our nation’s most vulnerable individuals.

However, we are concerned that recent policy changes proposed by the... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, drug prices

A Little Good, a Little Bad

Blog

The news often brings some good and some bad; sometimes a step forward and a step back. This week’s good news is the proposed change that would allow payment for advanced care planning visits with clinicians, encouraging dialogs that will help patients determine how they want care provided in serious... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: physician issues, physicians, Drug Pricing Program, advocacy, financial assistance, price

GAO Report Misses Mark on 340B Program

Blog

A July 6 Government Accountability Office (GAO) report examining Medicare Part B spending at hospitals participating in the 340B Drug Pricing Program draws unsubstantiated conclusions about a program that has a proven track record of improving access to care for poor patients and vulnerable communities.... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access

Keyword Search

Date